JOURNAL OF SULFUR CHEMISTRY
7
3.3.5. 3,3ꢀ-(1,3-Phenylene)bis(1,6-diphenyl-7-oxo-8-(benzylidene-spiro(5H-
thiazolo[2,2ꢀ]-3H-1,3,4-thiazole) (4e)
1
Yellow crystals, m.p. 168–170°C, yield (2.44 g, 94%). H NMR (300 MHz, CDCl3): δ
7.13–7.52 (m, 34H) and 7.84 (s, 2H, 2CH). GC/MS (m/z): 904 (M+). Anal. Calcd. for
C52H36N6O2S4 (904.90): C, 69.00; H, 4.01; N, 9.28; S, 14.17. Found: C, 69.05; H, 3.98; N,
9.22; S, 14.20.
3.3.6. 3,3ꢀ-(1,3-Phenylene)bis(1,6-diphenyl-7-oxo-8-(4-methylbenzylidene)-spiro(5H-
thiazolo[2,2ꢀ]-3H-1,3,4-thiazole) (4f)
Yellow crystals, m.p. 180–182°C, yield (2.44 g, 91%). 1H NMR (300 MHz, CDCl3): δ 2.40
(s, 6H, 2CH3), 6.71–7.40 (m, 32H) and 7.80 (s, 2H, 2CH). 13C NMR (75 MHz, CDCl3): δ
23.6, 101.2, 116.7, 120.8, 121.0, 124.1, 127.5, 128.0, 128.5, 128.7, 128.9, 129.2, 129.5, 130.7,
131.5, 132.2, 137.6, 138.8, 139.1, 141.8, 162.3. GC/MS (m/z): 932 (M+). Anal. Calcd. for
C54H40N6O2S4 (932.94): C, 69.50; H, 4.32; N, 9.01; S, 13.74. Found: C, 69.53; H, 4.35; N,
8.98; S, 13.76.
3.3.7. 3,3ꢀ-(1,3-Phenylene)bis(1,6-diphenyl-7-oxo-8-((cinnamylmethylene)-spiro(5H-
thiazolo[2,2ꢀ]-3H-1,3,4-thiazole) (4g)
Yellow crystals, m.p. 190–192°C, yield (2.44 g, 89%). 1H NMR (300 MHz, CDCl3): δ 6.70
(d, 2H, 2CH), 7.02 (d, 2H, 2CH) and 6.90–7.50 (m, 36H). 13C NMR (75 MHz, CDCl3) δ
101.3, 116.7, 118.5, 120.8, 121.0, 125.2, 127.5, 127.9, 128.0, 128.5, 128.6, 128.9, 129.5, 130.7,
131.5, 125.2, 138.4, 139.1, 141.8, 142.8, 143.8, 162.3. GC/MS (m/z): 956 (M+). Anal. Calcd.
for C56H40N6O2S4 (956.98): C, 70.27; H, 4.21; N, 8.78; S, 13.40. Found: C, 70.30; H, 4.19;
N, 8.76; S, 13.43.
3.3.8. 3,3ꢀ-(1,3-Phenylene)bis(1,6-diphenyl-7-oxo-8-(2-furylmethylene)-spiro(5H-
thiazolo[2,2ꢀ]-3H-1,3,4-thiazole) (4h)
1
Yellow crystals, m.p. 176–178°C, yield (2.23 g, 88%). H NMR (300 MHz, CDCl3): δ
6.8–8.10 (m, 32H). GC/MS (m/z): 884 (M+). Anal. Calcd. for C48H32N6O4S4 (884.82):
C, 65.14; H, 3.64; N, 9.50; S, 14.49. Found: C, 65.19; H, 3.61; N, 9.48; S, 14.43.
3.3.9. 3,3ꢀ-(1,3-Phenylene)bis(1,6-diphenyl-7-oxo-8-(4-dimethylamino-benzylidene)-
spiro(5H-thiazolo[2,2ꢀ]-3H-1,3,4-thiazole) (4i)
1
Orange crystals, m.p. 196–198°C, yield (2.62 g, 92%); IR (KBr) ν 1665 (CO) cm−1. H
NMR (300 MHz, CDCl3): δ 3.10 (s, 12H, 4CH3), 6.71–8.23 (m, 32H, ArH) and 8.49 (s, 2H,
2CH). 13C NMR (75 MHz, CDCl3) δ 41.3, 101.2, 111.7, 116.7, 121.0, 120.8, 124.1, 124.7,
127.5, 128.0, 128.9, 129.5, 129.7, 138.8, 139.1, 141.8, 143.8, 150.3. GC/MS (m/z): 991 (M+).
Anal. Calcd. for C56H46N8O2S4 (991.04): C, 67.85; H, 4.68; N, 11.30; S, 12.94. Found: C,
67.89; H, 4.63; N, 11.28; S, 12.90.
3.3.10. 3,3ꢀ-(1,3-Phenylene)bis(1,6-diphenyl-7-oxo-8-((4-florobenzylidene)-spiro(5H-
thiazolo[2,2ꢀ]-3H-1,3,4-thiazole) (4j)
Yellow crystals, m.p. 188–190°C, yield (2.53 g, 94%). GC/MS (m/z): 940 (M+). Anal. Calcd.
for C52H34F2N6O2S4 (940.88): C, 66.36; H, 3.64; F, 4.04; N, 8.93; S, 13.63. Found: C, 66.41;
H, 3.60; F, 3.99; N, 8.90; S, 13.65.